ASST Cremona

Cremona 80131

2 studies enrolling now · 4 studies all time

What they study most

Gastric Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer, Metastatic Urothelial Cancer, Monoclonal Antibody, Non-Small Cell Lung Cancer, Resectable Non-small Cell Lung Cancer

Studies at this site

• Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Recruiting now
• A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer — Recruiting now
• A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery — Running, not enrolling
• Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling